- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹6,391 Cr776th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 51.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 May 2026
- 3.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 7.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 May 2026
- 0.32
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,15,28652.9% delivered
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 7 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1,940 Crup 1.60%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹52 Crup 15.34%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 2.7%
Revenue by year
Peak revenue ₹6,591 Cr, year to Mar 2026
Net profit by year, a loss in red
| ₹ crore | Sep 2024Filed 13 Nov | Dec 2024Filed 13 Feb | Mar 2025Filed 12 Jun | Jun 2025Filed 8 Aug | Sep 2025Filed 12 Nov | Dec 2025Filed 12 Feb | Mar 2026Filed 25 May | Jun 2026Filed 7 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,301 | 1,359 | 1,339 | 1,404 | 1,571 | 1,707 | 1,910 | 1,940 |
| Net profit | 26 | 29 | 31 | 30 | 37 | 34 | 45 | 52 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 2.0% | 2.2% | 2.3% | 2.2% | 2.3% | 2.0% | 2.4% | 2.7% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Distribution of Pharmaceuticals, surgicals and other healthcare and allied products, which carries all its revenue.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.PE ratio and valuation history
Price to earningsPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
At or below today's level on 83% of 247 trading days over the last year.
LowestHighest
Its median46.0Industry median22.8
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 89% of 587 trading days since Jun 2024.
LowestHighest
Its median3.1Industry median2.5
EV to EBITDAEnterprise value to EBITDA. Market cap plus borrowings less cash and bank balances, divided by operating profit before depreciation (revenue less operating expenses, without other income and one-off items) over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly): what the whole business costs against the profit its operations make. Lease liabilities are not counted: the results filings do not state them.21.7
At or below today's level on 32% of 247 trading days over the last year.
LowestHighest
Its median23.2Industry median11.7
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +9.7% | +21.3% | −9.5% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Mutual funds holding it
26 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 6 of the 17 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.Mutual fund holdings
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 4
- AddedAdded. Funds that held more shares than at the end of the month before.
- 4
- CutCut. Funds that held fewer shares than at the end of the month before.
- 13
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 5
| Fund | |||
|---|---|---|---|
 Invesco India Contra FundInvesco Mutual Fund | 11,92,406 | 1.06% | ₹203.8 Cr |
 HDFC Balanced Advantage FundHDFC Mutual Fund | 11,83,000 | 0.20% | ₹202.2 Cr |
 Bank of India Flexi Cap FundBank of India Mutual Fund | 4,09,613 | 2.26% | ₹70.0 Cr |
 ICICI Prudential Healthcare FundICICI Prudential Mutual Fund | 2,97,995 | 0.74% | ₹50.9 Cr |
 Edelweiss Small Cap FundEdelweiss Mutual Fund | 2,82,466 | 0.69% | ₹48.3 Cr |
| Bank of India Small Cap FundBank of India Mutual Fund | 2,32,276 | 1.08% | ₹39.7 Cr |
| Bank of India Multi Cap FundBank of India Mutual Fund | 2,16,835 | 2.76% | ₹37.1 Cr |
| HDFC Pharma and Healthcare FundHDFC Mutual Fund | 2,07,000 | 1.01% | ₹35.4 Cr |
 Motilal Oswal Innovation Opportunities FundMotilal Oswal Mutual Fund | 1,59,188 | 3.18% | ₹27.2 Cr |
| Invesco India ELSS Tax Saver FundInvesco Mutual Fund | 1,53,434 | 1.01% | ₹26.2 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Peers and competitors
Retailing, 82 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Entero Healthcare Solutions in market cap.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Aditya Birla Lifestyle BrandsABLBL | 8,623 | 49.0 | 6.1 | 6.7 | – | – | 12.5% | 25.0% | 0.71% |
 Brainbees SolutionsFIRSTCRY | 8,513 | – | 1.8 | 26.7 | +11.7% | – | −2.6% | −1.9% | 0.00% |
 Aditya VisionAVL | 7,167 | 51.6 | 10.4 | 28.1 | +26.5% | +29.2% | 21.9% | 21.5% | 0.23% |
 Medplus Health ServicesMEDPLUS | 7,150 | 34.0 | 3.6 | 11.0 | +16.8% | +18.0% | 11.3% | 15.9% | 0.00% |
 V-Mart RetailVMART | 6,185 | 44.9 | 6.5 | 11.4 | +19.1% | +104.7% | 15.6% | 22.3% | 0.13% |
 Just DialJUSTDIAL | 6,004 | 12.2 | 1.1 | 14.6 | +9.0% | −13.4% | 9.6% | 6.0% | 0.00% |
 V2 RetailV2RETAIL | 5,937 | 33.2 | 6.6 | 12.2 | +63.3% | +122.3% | 28.6% | 25.4% | 0.00% |
 Electronics Mart IndiaEMIL | 5,910 | 28.7 | 3.6 | 11.9 | +16.8% | +88.8% | 13.1% | 16.2% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
Sep 2026
22 Sep · Analysts
Aug 2026
24 Aug · Analysts
Entero Healthcare Solutions share price by year
Each calendar year to 2025.Entero Healthcare Solutions share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 1,026.60 | −27.9% | 1,549.55 | 949.20 |
| 2024 | 1,424.15 | – | 1,534.80 | 986.50 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2024 is from its first session, 16 Feb 2024.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 1,471.00 | 1,482.20 | 1,436.30 | 1,468.40 | 1,463.69 | 2,15,286 | 52.9% |
| 22 Oct 2026 | 1,484.20 | 1,518.40 | 1,458.30 | 1,498.90 | 1,493.17 | 81,582 | 43.4% |
| 21 Oct 2026 | 1,519.50 | 1,537.20 | 1,459.00 | 1,485.30 | 1,482.20 | 1,09,497 | 47.4% |
| 19 Oct 2026 | 1,591.00 | 1,591.00 | 1,497.30 | 1,503.90 | 1,526.96 | 1,65,045 | 57.5% |
| 16 Oct 2026 | 1,575.10 | 1,624.60 | 1,550.00 | 1,585.00 | 1,571.99 | 71,740 | 51.3% |
| 15 Oct 2026 | 1,600.00 | 1,600.00 | 1,555.20 | 1,581.10 | 1,578.45 | 86,974 | 49.3% |
| 14 Oct 2026 | 1,610.00 | 1,646.20 | 1,585.00 | 1,591.70 | 1,601.65 | 70,006 | 42.7% |
| 13 Oct 2026 | 1,646.00 | 1,661.10 | 1,591.20 | 1,614.20 | 1,610.66 | 1,26,001 | 52.4% |
| 12 Oct 2026 | 1,665.50 | 1,698.00 | 1,636.10 | 1,644.10 | 1,660.76 | 75,381 | 58.5% |
| 9 Oct 2026 | 1,699.90 | 1,721.60 | 1,652.60 | 1,676.20 | 1,672.24 | 93,478 | 49.4% |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Entero Healthcare Solutions Limited
- NSE symbol
- ENTERO
- BSE code
- 544122
- ISIN
- INE010601016
- Industry
- Retailing
- Listed
- Feb 2024
- Face value
- ₹10
- CIN
- L74999HR2018PLC072204
- Corporate identity number, the registrar of companies' code for it